Completed PHASE3 INTERVENTIONAL 2-arm NCT03983980

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults

Sponsor: IQVIA Biotech

Updated 12 times since 2019 Last updated: May 30, 2025 Started: Jun 6, 2019 Primary completion: May 13, 2020 Completion: May 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Plaque Psoriasis, this trial is completed. The trial is conducted by IQVIA Biotech and has accumulated 12 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Jul 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Jul 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Nov 2022 — Jul 2024 [monthly]

Completed PHASE3
Apr 2022 — Nov 2022 [monthly]

Completed PHASE3

▶ Show 7 earlier versions

Jan 2022 — Apr 2022 [monthly]

Completed PHASE3
Sep 2021 — Jan 2022 [monthly]

Completed PHASE3
Jan 2021 — Sep 2021 [monthly]

Completed PHASE3
Nov 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
May 2020 — Nov 2020 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Aug 2019 — May 2020 [monthly]

Recruiting PHASE3
Jul 2019 — Aug 2019 [monthly]

Recruiting PHASE3

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IQVIA Biotech
Organon and Co

Data source: Organon and Co

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bay City, United States , Beachwood, United States , Bexley, United States , Boise, United States , Boston, United States , Boynton Beach, United States , Charleston, United States , Denver, United States , Detroit, United States , East Windsor, United States and 39 more locations